Tell Pharmaceutical Companies to Stop Putting Profits over Patients

The recent actions by the EpiPen manufacturer, Mylan, are a perfect example of why pharmaceutical companies need to stop hiking up prescription drug prices to exorbitant levels.

Mylan raised the price of its lifesaving EpiPen by 400%, rendering it unaffordable for many people with life-threatening allergies.

And when it started facing public scrutiny, Mylan didn’t lower the price. Instead, it essentially offered a discount card to families. But this is just a shell game — it keeps the prices high by putting insurers and government programs on the hook for the entire cost.

This places a burden on our health care system that could raise consumer premiums in the long run. Join me and tell pharmaceutical companies to stop putting profits over the needs of patients.